Skip to content

Company wants to market sleep drug for jet lag

Just in time for holiday travel, the Wall Street Journal's Health Blog is reporting on a prescription drug to potentially treat jet lag. The Cephalon drug Provigil is FDA-approved to "improve wakefulness" for patients with certain sleep disorders; now the company wants to market it for jet lag. Here's the latest:

Cephalon applied for the approval earlier this year for its drug Nuvigil. The company said a study of 427 people who flew from the Eastern U.S. to France showed that those who took the drug had less jet lag than those who took placebo.

A decision from the FDA was expected this month, but the company said yesterday that the FDA had pushed back the decision deadline by a few months.

Popular posts

Category:
Cancer
A better COVID-19 vaccine?

A new way to deliver mRNA as a COVID-19 vaccine may avoid side effects and increase customization to prevent infection.